D.A. Davidson & Co. Adma Biologics, Inc. Transaction History
D.A. Davidson & Co.
- $12.1 Billion
- Q4 2024
A detailed history of D.A. Davidson & Co. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, D.A. Davidson & Co. holds 11,760 shares of ADMA stock, worth $199,332. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,760Holding current value
$199,332% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
323Shares Held
190MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$316 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$307 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$220 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$214 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$146 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.33B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...